Company Profiles

driven by the PitchBook Platform

KYDES Pharmaceuticals

KYDES Pharmaceuticals
2008 FOUNDED
PRIVATE STATUS
Early Stage VC LATEST DEAL TYPE
$75k LATEST DEAL AMOUNT
$375k TOTAL AMOUNT RAISED
2 INVESTORS
Description

Developer of pharmaceutical products. The company develops KY1101 and KY1102, a drug for pain management, KY1103 a drug for the treatment of malignant and non-malignant, proliferative gynecological disorders such as cervical, vaginal, uterine cancers, heavy menstrual bleeding, adenomyosis, endometriosis, cervical dysplasia and fibroids, KY1104, a topical microbicides for Human Immunodeficiency Virus (HIV) prevention, KY1105, a drug for the treatment for curing Human Immunodeficiency Virus (HIV) infection and cervical displasia, KY1106, an anti-adherent technology and KY1107, an abuse deterrent opiate formulations.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
University of Maryland Baltimore County Research & Technology Park
1450 South Rolling Road
Halethorpe, MD 21227
United States

+1 (410) 499-7379
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore KYDES Pharmaceuticals’s full profile, request a free trial.

KYDES Pharmaceuticals Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 01-Sep-2012 $75k $375k Completed Startup
1. Accelerator/Incubator 12-Aug-2010 00000 00000 Completed Startup
To view this company’s complete deal history including valuation and funding request access »

KYDES Pharmaceuticals Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Maryland Industrial Partnerships Accelerator/Incubator Minority 000 0000 000000 0
TEDCO Venture Capital Minority 000 0000 000000 0

KYDES Pharmaceuticals Executive Team (1)

Name Title Board
Seat
Contact
Info
Stephen Dordunoo Chief Scientific Officer, Chief Executive Officer, President and Founder